01-10-2019 02:22 PM CET - Health & Medicine
Print

Cholesterol Testing Market by Emerging Trends by Global Key Player 2019: F. Hoffmann-La Roche Ltd, Siemens AG, Abbott, Accutech, LLC, Beckman Coulter, Bio-Rad Laboratories, Prima Lab SA, Quest Diagnostics, Home Access Health Corporation, and Sigma-Aldrich

Press release from: Data Bridge Market Research
Cholesterol Testing Market
Cholesterol Testing Market


Global Cholesterol Testing Market is expected to reach USD 10,290.57 million by 2025 from USD 5,727.60 million in 2018, at a CAGR of 7.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Drivers:

The major factors driving the growth of this market are technological advancements in cholesterol testing, growing number of cardiovascular diseases and obesity, higher growing number of geriatric population, rising awareness and acceptance of preventive healthcare and increasing cholesterol home/self-testing market are boosting the growth of the global cholesterol testing market.

Download PDF Sample Copy of Report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

TECHNOLOGICAL ADVANCEMENTS IN CHOLESTEROL TESTING

Cholesterol testing is the method which is used for diagnosis of the cholesterol level in the body. Much technological advancement had taken place in the cholesterol testing procedures as there had been innovative technologies. Some of the example for technological advancements is mentioned below.

• In July 2016, Alere entered into a partnership with healthcare technology company BioIQ for providing interface between BioIQ’s software platform, SoftSuite Dx and the Alere Cholestech LDX System for the point of care lipid profile and glucose results for employee biometric screening events.

• In November 2014, Roche Diagnostics Ltd. received FDA Clearance for Strep A Test on cobasLiat System, the first molecular point of care test.

The new technologies are emerging in the market that is helpful for the non-invasive techniques of cholesterol testing. This will enhance the growth of the cholesterol testing market.

GROWING NUMBER OF CARDIOVASCULAR DISEASES AND OBESITY

Cardiovascular diseases (CVDs) are the disorders that affect the heart and blood vessels and it comprises of cerebrovascular disease, coronary heart disease, rheumatic heart disease and other conditions. The individuals with cardiovascular diseases are at a higher risk of some common problems such as glucose, blood pressure and lipids, overweight and obesity. The risen cholesterol levels are one of the major factors in the rise of heart diseases. Some of the statistics for cardiovascular disease and obesity is mentioned below:

• According to Centers for Disease Control and Prevention (CDC), approximately 610,000 people die due to heart disease in the U.S. per year.

• According to European Heart Network, every year cardiovascular disease leads to 3.9 million deaths in Europe and around 1.8 million deaths in the European Union.

• According to American Heart Association, in the U.S. more than one-third (approximately 35.0%) of adults are obese (over 78 million adults).

• According to Heart Foundation, in 2011, the prevalence of high cholesterol increases in the age of 55 to 64 years, and half of the population among them have high total cholesterol level.

Rising number of obesity and cardiovascular diseases leads to high blood cholesterol and triglyceride levels which increase the cholesterol testing requirement leading to growth of the market.

Market is further segmented into:

By Product Type (Test Kits, Testing Strips),

By Test (Lipid Panel Test/Complete Lipid Profile {Total Cholesterol Test, HDL Cholesterol Test, LDL Cholesterol Test, Triglycerides/VLDL Cholesterol Test},

By Test Type (Non-Invasive, Invasive),

By Prescription Mode (Over The Counter, Prescription Based),

By End-Users (Clinics, Hospitals, Ambulatory Centers, Homecare, Diagnostic Centers),

By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)

Purchase Full Detail TOC of Global Cholesterol Testing Market @ databridgemarketresearch.com/toc/?dbmr=global-cholesterol...

Top key market players:

• Abbott Laboratories
• Accutech, LLC
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• Prima Lab SA
• Quest Diagnostics, Inc.
• Home Access Health Corporation
• F. Hoffmann-La Roche AG
• Siemens AG
• Sigma-Aldrich Corp.

Competitors Analysis:

F. HOFFMANN-LA ROCHE LTD:

Established in 1896 and headquartered at Basel, Switzerland. F. Hoffmann-La Roche Ltd. is one of the largest biotech companies with 17 biopharmaceuticals on the market. Since the establishment in 1896, the company is focused into manufacturing of products for oncology, immunology, ophthalmology, infectious diseases and neuroscience. The company is operating in more than 100 countries around the globe. Some of the subsidiaries are Genetech, Roche Diagnostics, Chugai Pharmaceutical Co., Ventana Medical Systems, InterMune, Inc., Syntex, Anadys Pharmaceuticals, Roche Applied Science, Bioveris, Roche products, Inc., Roche pharma AG, Pt Roche Indonesia, Bina Technologies, Inc., NV Roche SA, Roche SAS, Roche Glycart AG, and Roche Co., Ltd.

SIEMENS AG:

Founded in 1847 and headquartered in Munich, Germany. Siemens is involved in the field of automation, electrification and digitalization. Siemens comprises Siemens AG, a stock corporation under the federal laws of the company and its subsidiaries. The company's operations spans across Europe, Commonwealth of Independent States (C.I.S), Africa, Middle East, Americas, Asia and Australia.

Siemens operates in eight business segments: power and gas, wind power and renewables, energy management, building technologies, mobility, digital factory and process industries and drives and healthineers.

ABBOTT:

Abbott was incorporated in 1990 and headquartered in Illinois, U.S. It is a globally diversified healthcare company focused in discovery, development, manufacture, and marketing of broad line of health care products. It operates its business through four segments, established pharmaceutical products, diagnostic products, nutritional products, and vascular products.

Request for Detail Report Enquire Click Here @: databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Related Report

Global Point-Of-Care Diagnostics Market – Industry Trends and Forecast to 2024

Global Point-Of-Care Diagnostics Market By Disease (Diabetes, Cardiac, Coagulation, Cholesterol, Urinary, Blood Gas, Drug Of Abuse, Infectious, Pregnancy & Fertility, Cancer, Hematology, Others), By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), by Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Report Access: databridgemarketresearch.com/reports/global-point-of-care...

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1487595 • Views: 107
More releasesMore releases

You can edit or delete your press release here: